tirzepatide vs semaglutide side effects comparison study vs. for Weight Loss GLP-1 Medications for Weight Loss:

Serious but rare risks include pancreatitis, gallbladder disease, acute kidney injury (usually secondary to dehydration), and hypoglycemia when used with insulin or sulfonylureas

How tirzepatide compares to other GLP-1 medications by delivery method Tirzepatide is not the only GLP-1 receptor agonist available

Discussion This one-year audit of 222 pancreatitis admissions in a UK DGH identified four patients (1.8%) who developed acute pancreatitis while receiving tirzepatide (Mounjaro)

Most side effects are mild, like nausea, tiredness, or diarrhoea, and improve as your body adjusts

After a grilling on Capitol Hill in September 2024, pharmaceutical company Novo Nordisk came under intense pressure to offer patients without prescription coverage a lower-priced product for its brand-name Wegovy as well